Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 64

    1.

    BDNF regulates neuronal sensitivity to endocannabinoids.

    Maison P, Walker DJ, Walsh FS, Williams G, Doherty P.

    Neurosci Lett. 2009 Dec 25;467(2):90-4. Epub 2009 Oct 8.PMID: 19818836 [PubMed - in process]Related articles

    2.

    Prediction of myocardial infarction risk in older patients with acute coronary syndrome.

    Ngako A, Santin A, Hémery F, Salloum M, Calmettes MJ, Hervé J, Grégo JC, Roupie E, Maison P, Renaud B.

    Am J Emerg Med. 2009 Jul;27(6):675-82.PMID: 19751624 [PubMed - indexed for MEDLINE]Related articles

    3.

    Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction.

    Couette M, Boisse MF, Maison P, Brugieres P, Cesaro P, Chevalier X, Gherardi RK, Bachoud-Levi AC, Authier FJ.

    J Inorg Biochem. 2009 Nov;103(11):1571-8. Epub 2009 Aug 20.PMID: 19748679 [PubMed - in process]Related articles

    4.

    [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]

    Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

    Encephale. 2009 Sep;35(4):330-9. Epub 2009 Jul 9. French. PMID: 19748369 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of four right ventricular systolic echocardiographic parameters to predict adverse outcomes in chronic heart failure.

    Damy T, Viallet C, Lairez O, Deswarte G, Paulino A, Maison P, Vermes E, Gueret P, Adnot S, Dubois-Randé JL, Hittinger L.

    Eur J Heart Fail. 2009 Sep;11(9):818-24.PMID: 19696055 [PubMed - in process]Related articles

    6.

    A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease.

    Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I, Cazeneuve C, Charles P, Maison P, Debruxelles S, Verny C, Gervais H, Azulay JP, Tranchant C, Bachoud-Levi AC, Dürr A, Buée L, Krystkowiak P, Sablonnière B, Blum D; Huntington French Speaking Network.

    Neurobiol Dis. 2009 Sep;35(3):474-6. Epub 2009 Jul 8.PMID: 19591938 [PubMed - in process]Related articles

    7.

    Dopamine transporter imaging under high-dose transdermal nicotine therapy in Parkinson's disease: an observational study.

    Itti E, Villafane G, Malek Z, Brugières P, Capacchione D, Itti L, Maison P, Cesaro P, Meignan M.

    Nucl Med Commun. 2009 Jul;30(7):513-8.PMID: 19451839 [PubMed - indexed for MEDLINE]Related articles

    8.

    D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly.

    Kamenicky P, Dos Santos C, Espinosa C, Salenave S, Galland F, Le Bouc Y, Maison P, Bougnères P, Chanson P.

    Eur J Endocrinol. 2009 Aug;161(2):231-5. Epub 2009 May 13.PMID: 19439509 [PubMed - indexed for MEDLINE]Related articles

    9.

    Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain.

    Lefaucheur JP, Drouot X, Cunin P, Bruckert R, Lepetit H, Créange A, Wolkenstein P, Maison P, Keravel Y, Nguyen JP.

    Brain. 2009 Jun;132(Pt 6):1463-71. Epub 2009 Mar 31.PMID: 19336459 [PubMed - indexed for MEDLINE]Related articles

    10.

    Neuroendocrine disturbances in Huntington's disease.

    Saleh N, Moutereau S, Durr A, Krystkowiak P, Azulay JP, Tranchant C, Broussolle E, Morin F, Bachoud-Lévi AC, Maison P.

    PLoS One. 2009;4(3):e4962. Epub 2009 Mar 25.PMID: 19319184 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

    Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, Dhédin N, Isnard F, Ades L, Kuhnowski F, Foulet F, Kuentz M, Maison P, Bretagne S, Schwarzinger M.

    Clin Infect Dis. 2009 Apr 15;48(8):1042-51.PMID: 19281327 [PubMed - indexed for MEDLINE]Related articles

    12.

    Patients with plasma cell disorders examined at whole-body dynamic contrast-enhanced MR imaging: initial experience.

    Lin C, Luciani A, Belhadj K, Maison P, Vignaud A, Deux JF, Zerbib P, Pigneur F, Itti E, Kobeiter H, Haioun C, Rahmouni A.

    Radiology. 2009 Mar;250(3):905-15.PMID: 19244054 [PubMed - indexed for MEDLINE]Related articles

    13.

    Does attainment of target levels of growth hormone and insulin-like growth factor I improve acromegaly prognosis?

    Chanson P, Maison P.

    Nat Clin Pract Endocrinol Metab. 2009 Feb;5(2):70-1. No abstract available. PMID: 19165217 [PubMed]Related articles

    14.

    Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.

    Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P.

    Pediatrics. 2009 Feb;123(2):e297-304. Epub 2009 Jan 19.PMID: 19153164 [PubMed - indexed for MEDLINE]Related articles

    15.

    Ex vivo MRI of axillary lymph nodes in breast cancer.

    Luciani A, Pigneur F, Ghozali F, Dao TH, Cunin P, Meyblum E, De Baecque-Fontaine C, Alamdari A, Maison P, Deux JF, Lagrange JL, Lantieri L, Rahmouni A.

    Eur J Radiol. 2009 Jan;69(1):59-66. Epub 2008 Dec 27.PMID: 19112002 [PubMed - indexed for MEDLINE]Related articles

    16.

    Impact of written information describing postoperative pain management on patient agreement with proposed treatment.

    Binhas M, Roudot-Thoraval F, Thominet D, Maison P, Marty J.

    Eur J Anaesthesiol. 2008 Nov;25(11):884-90. Epub 2008 Jul 24.PMID: 18652711 [PubMed - indexed for MEDLINE]Related articles

    17.

    [French survey of neuromuscular relaxant use in anaesthetic practice in adults]

    Duvaldestin P, Cunin P, Plaud B, Maison P.

    Ann Fr Anesth Reanim. 2008 Jun;27(6):483-9. Epub 2008 Jun 20. French. PMID: 18571891 [PubMed - indexed for MEDLINE]Related articles

    18.

    Impact of point-of-care testing in the emergency department evaluation and treatment of patients with suspected acute coronary syndromes.

    Renaud B, Maison P, Ngako A, Cunin P, Santin A, Hervé J, Salloum M, Calmettes MJ, Boraud C, Lemiale V, Grégo JC, Debacker M, Hémery F, Roupie E.

    Acad Emerg Med. 2008 Mar;15(3):216-24.PMID: 18304051 [PubMed - indexed for MEDLINE]Related articles

    19.

    Chronic high dose transdermal nicotine in Parkinson's disease: an open trial.

    Villafane G, Cesaro P, Rialland A, Baloul S, Azimi S, Bourdet C, Le Houezec J, Macquin-Mavier I, Maison P.

    Eur J Neurol. 2007 Dec;14(12):1313-6. Epub 2007 Oct 17.PMID: 17941858 [PubMed - indexed for MEDLINE]Related articles

    20.

    Expression of inosine monophosphate dehydrogenase type I and type II after mycophenolate mofetil treatment: a 2-year follow-up in kidney transplantation.

    Sanquer S, Maison P, Tomkiewicz C, Macquin-Mavier I, Legendre C, Barouki R, Lang P.

    Clin Pharmacol Ther. 2008 Feb;83(2):328-35. Epub 2007 Aug 22.PMID: 17713475 [PubMed - indexed for MEDLINE]Related articles

    21.

    Transient worsening of renal function during hospitalization for acute heart failure alters outcome.

    Logeart D, Tabet JY, Hittinger L, Thabut G, Jourdain P, Maison P, Tartiere JM, Solal AC.

    Int J Cardiol. 2008 Jul 4;127(2):228-32. Epub 2007 Jul 24.PMID: 17651843 [PubMed - indexed for MEDLINE]Related articles

    22.

    Evidence for distinct effects of GH and IGF-I in the metabolic syndrome.

    Maison P, Balkau B, Souberbielle JC, Cunin P, Vol S, Macquin-Mavier I, Eschwège E; D. E. S. I. R. Study Group.

    Diabet Med. 2007 Sep;24(9):1012-8. Epub 2007 May 29.PMID: 17535291 [PubMed - indexed for MEDLINE]Related articles

    23.

    Walking capacities in multiple sclerosis measured by global positioning system odometer.

    Créange A, Serre I, Levasseur M, Audry D, Nineb A, Boërio D, Moreau T, Maison P; Réseau SINDEFI-SEP.

    Mult Scler. 2007 Mar;13(2):220-3. Epub 2007 Jan 29.PMID: 17439888 [PubMed - indexed for MEDLINE]Related articles

    24.

    Improvement of the comprehension of written information given to healthy volunteers in biomedical research: a single-blind randomized controlled study.

    Paris A, Nogueira da Gama Chaves D, Cornu C, Maison P, Salvat-Mélis M, Ribuot C, Brandt C, Bosson JL, Hommel M, Cracowski JL.

    Fundam Clin Pharmacol. 2007 Apr;21(2):207-14.PMID: 17391294 [PubMed - indexed for MEDLINE]Related articles

    25.

    Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis.

    Maison P, Tropeano AI, Macquin-Mavier I, Giustina A, Chanson P.

    J Clin Endocrinol Metab. 2007 May;92(5):1743-7. Epub 2007 Feb 20. Review.PMID: 17311857 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Less is more risky? Growth hormone and insulin-like growth factor 1 levels and cardiovascular risk.

    Maison P, Chanson P.

    Nat Clin Pract Endocrinol Metab. 2006 Dec;2(12):650-1. No abstract available. PMID: 17143307 [PubMed - indexed for MEDLINE]Related articles

    27.

    Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis.

    Le Corvoisier P, Hittinger L, Chanson P, Montagne O, Macquin-Mavier I, Maison P.

    J Clin Endocrinol Metab. 2007 Jan;92(1):180-5. Epub 2006 Oct 24.PMID: 17062772 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Electrophysiological deterioration over time in patients with Huntington's disease.

    Lefaucheur JP, Ménard-Lefaucheur I, Maison P, Baudic S, Cesaro P, Peschanski M, Bachoud-Lévi AC.

    Mov Disord. 2006 Sep;21(9):1350-4.PMID: 16721731 [PubMed - indexed for MEDLINE]Related articles

    29.

    Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study.

    Bachoud-Lévi AC, Gaura V, Brugières P, Lefaucheur JP, Boissé MF, Maison P, Baudic S, Ribeiro MJ, Bourdet C, Remy P, Cesaro P, Hantraye P, Peschanski M.

    Lancet Neurol. 2006 Apr;5(4):303-9.PMID: 16545746 [PubMed - indexed for MEDLINE]Related articles

    30.

    Cognitive impairment related to apathy in early Huntington's disease.

    Baudic S, Maison P, Dolbeau G, Boissé MF, Bartolomeo P, Dalla Barba G, Traykov L, Bachoud-Lévi AC.

    Dement Geriatr Cogn Disord. 2006;21(5-6):316-21. Epub 2006 Feb 14.PMID: 16484810 [PubMed - indexed for MEDLINE]Related articles

    31.

    French adaptation and preliminary validation of a questionnaire to evaluate understanding of informed consent documents in phase I biomedical research.

    Paris A, Cornu C, Auquier P, Maison P, Radauceanu A, Brandt C, Salvat-Melis M, Hommel M, Cracowski JL.

    Fundam Clin Pharmacol. 2006 Feb;20(1):97-104.PMID: 16448400 [PubMed - indexed for MEDLINE]Related articles

    32.

    Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study.

    Maison P, Cunin P, Hemery F, Fric F, Elie N, Del'volgo A, Dubois-Randé JL, Hittinger L, Macquin-Mavier I.

    Eur J Clin Pharmacol. 2005 Jul;61(5-6):445-51. Epub 2005 Jun 7.PMID: 15940531 [PubMed - indexed for MEDLINE]Related articles

    33.

    Impact of French 'Comités de Protection des Personnes' on the readability of informed consent documents (ICD) in biomedical research: more information, but not better information.

    Paris A, Cracowski JL, Maison P, Radauceanu A, Cornu C, Hommel M.

    Fundam Clin Pharmacol. 2005 Jun;19(3):395-9.PMID: 15910664 [PubMed - indexed for MEDLINE]Related articles

    34.

    A complementary peptide approach applied to the design of novel semaphorin/neuropilin antagonists.

    Williams G, Eickholt BJ, Maison P, Prinjha R, Walsh FS, Doherty P.

    J Neurochem. 2005 Mar;92(5):1180-90.PMID: 15715668 [PubMed - indexed for MEDLINE]Related articles

    35.

    Overcoming the inhibitors of myelin with a novel neurotrophin strategy.

    Williams G, Williams EJ, Maison P, Pangalos MN, Walsh FS, Doherty P.

    J Biol Chem. 2005 Feb 18;280(7):5862-9. Epub 2004 Nov 30.PMID: 15572360 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.

    Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P; Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.

    J Clin Endocrinol Metab. 2004 May;89(5):2192-9.PMID: 15126541 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Estimation of the prevalence of orally treated diabetes in France using a pharmacoepidemiologic approach: comparison between 1981 and 1992.

    Vauzelle-Kervroëdan F, Forhan A, Guillemot D, Sermet C, Maison P, Balkau B, Eschwège E.

    Pharmacoepidemiol Drug Saf. 1999 Dec;8(7):519-22.PMID: 15073895 [PubMed]Related articles

    38.

    Peripheral blood lymphocyte phenotypes in patients with spondyloarthropathy.

    Plonquet A, Gleizes A, Briot K, Maison P, Chevalier X, Farcet JP, Claudepierre P.

    Ann Rheum Dis. 2004 Apr;63(4):467-8. No abstract available. PMID: 15020352 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis.

    Maison P, Chanson P.

    Circulation. 2003 Nov 25;108(21):2648-52. Epub 2003 Nov 17.PMID: 14623813 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Adenoviral transgene ubiquitination enhances mouse immunization and class I presentation by human dendritic cells.

    Rouard H, Klonjkowski B, Marquet J, Lahet C, Mercier S, Andrieu M, Maison P, Molinier-Frenkel V, Eloit M, Farcet JP, Langlade-Demoyen P, Delfau-Larue MH.

    Hum Gene Ther. 2003 Sep 20;14(14):1319-32.PMID: 14503967 [PubMed - indexed for MEDLINE]Related articles

    41.

    A closed and single-use system for monocyte enrichment: potential for dendritic cell generation for clinical applications.

    Rouard H, Leon A, De Reys S, Taylor L, Logan J, Marquet J, Jouault H, Loper K, Maison P, Delfau-Larue MH, Beaujean F, Farcet JP, Noga SJ.

    Transfusion. 2003 Apr;43(4):481-7.PMID: 12662281 [PubMed - indexed for MEDLINE]Related articles

    42.

    Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barré syndrome and experimental autoimmune neuritis.

    Orlikowski D, Chazaud B, Plonquet A, Poron F, Sharshar T, Maison P, Raphaël JC, Gherardi RK, Créange A.

    J Neuroimmunol. 2003 Jan;134(1-2):118-27.PMID: 12507779 [PubMed - indexed for MEDLINE]Related articles

    43.

    IL-12 secreting dendritic cells are required for optimum activation of human secondary lymphoid tissue T cells.

    Rouard H, Marquet J, Léon A, Maison P, Haioun C, Copie-Bergman C, Plonquet A, Farcet JP, Delfau-Larue MH.

    J Immunother. 2002 Jul-Aug;25(4):324-33.PMID: 12142555 [PubMed - indexed for MEDLINE]Related articles

    44.

    Focal nodular hyperplasia of the liver in men: is presentation the same in men and women?

    Luciani A, Kobeiter H, Maison P, Cherqui D, Zafrani ES, Dhumeaux D, Mathieu D.

    Gut. 2002 Jun;50(6):877-80.PMID: 12010893 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Trends in antihypertensive drug use among orally treated diabetic patients, in France between 1981 and 1992. Impact of guidelines and new drugs.

    Maison P, Planchat-Fely P, Vauzelle-Kervroëdan F, Sermet C, Eschwège E.

    Diabetes Metab. 2001 Dec;27(6):661-5.PMID: 11852374 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    A pharmacoepidemiological assessment of the effect of statins and fibrates on fibrinogen concentration.

    Maison P, Mennen L, Sapinho D, Balkau B, Sigalas J, Chesnier MC, Eschwège E; D.E.S.I.R. Study Group.

    Atherosclerosis. 2002 Jan;160(1):155-60.PMID: 11755933 [PubMed - indexed for MEDLINE]Related articles

    47.

    Brainstem gliomas in adults: prognostic factors and classification.

    Guillamo JS, Monjour A, Taillandier L, Devaux B, Varlet P, Haie-Meder C, Defer GL, Maison P, Mazeron JJ, Cornu P, Delattre JY; Association des Neuro-Oncologues d'Expression Française (ANOCEF).

    Brain. 2001 Dec;124(Pt 12):2528-39.PMID: 11701605 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature.

    Maison P, Byrne CD, Hales CN, Day NE, Wareham NJ.

    Diabetes Care. 2001 Oct;24(10):1758-63.PMID: 11574438 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Retest effects and cognitive decline in longitudinal follow-up of patients with early HD.

    Bachoud-Lévi AC, Maison P, Bartolomeo P, Boissé MF, Dalla Barba G, Ergis AM, Baudic S, Degos JD, Cesaro P, Peschanski M.

    Neurology. 2001 Apr 24;56(8):1052-8.PMID: 11320178 [PubMed - indexed for MEDLINE]Related articles

    50.

    Motor and cognitive improvements in patients with Huntington's disease after neural transplantation.

    Bachoud-Lévi AC, Rémy P, Nguyen JP, Brugières P, Lefaucheur JP, Bourdet C, Baudic S, Gaura V, Maison P, Haddad B, Boissé MF, Grandmougin T, Jény R, Bartolomeo P, Dalla Barba G, Degos JD, Lisovoski F, Ergis AM, Pailhous E, Cesaro P, Hantraye P, Peschanski M.

    Lancet. 2000 Dec 9;356(9246):1975-9.PMID: 11130527 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...